✦ LIBER ✦

8720 Improved survival in patients with refractory glioblastoma that response to Irinotecan and Bevacizumab

✍ Scribed by Hernandez-Jorge, A.; Reyna, C.; Espinós, J.; delaCruz, S.; Santisteban, M.; Fernandez-Hidalgo, O.; Aramendia, J.M.; Aristu, J.J.; Garcia-Foncillas, J.

Book ID: 122818637
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 46 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71694-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of bevacizumab plus irinotecan o

Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis

✍ Tao Xu; Juxiang Chen; Yicheng Lu; Johannes EA Wolff 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 795 KB

Pathologic response to bevacizumab-conta

Pathologic response to bevacizumab-containing chemotherapy in patients with colorectal liver metastases and its correlation with survival

✍ Gruenberger, T.; Arnold, D.; Rubbia-Brandt, L. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 558 KB

279 Correlation of acne rash and tumor r

279 Correlation of acne rash and tumor response with cetuximab monotherapy in patients with colorectal cancer refractory to both irinotecan and oxaliplatin

✍ E. Van Cutsem; R.J. Mayer; P. Gold; P. Stella; A. Cohn; A. Pippas; P. Windt; P. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 271 KB

832 Ifosfamide, carboplatin, etoposide i

832 Ifosfamide, carboplatin, etoposide induces a 50% overall response rate and 1 year overall survival rate in patients with recurrent/refractory soft tissue and bone sarcoma: Embryonal rhabdomyosarcoma histology and complete response to ICE are independent factors significantly associated with improved survival

✍ M.S. Cairo; V. Davenport; P. Van Winkle; K. Cheung; A. Angiolillo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Addition of Aflibercept to Fluorouracil,

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

✍ Van Cutsem, E.; Tabernero, J.; Lakomy, R.; Prenen, H.; Prausova, J.; Macarulla, 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 532 KB

Prediction of response to interferon in

Prediction of response to interferon in patients with chronic active hepatitis C, and evidence that this improves hepatic metabolic function

✍ Farrell, Geoffrey C. ;Lin, Rita ;Coverdale, Shirley 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 343 KB